HOME - Companies - News
 
 
12 December 2023

Vivos Therapeutics Presents: “Empowering Women to Champion Airway”


Vivos Therapeutics is excited to announce “Empowering Women to Champion Airway,” a pioneering event that will transcend international boundaries and unite prominent women in the medical and dental fields to shed light on the pivotal role of airway health in human well-being.

The “Empowering Women to Champion Airway” conference will be held at the Vivos Institute in Denver, CO on February 1 and 2, 2024. This unprecedented assembly aims to forge stronger bonds between medical and dental professionals, with a specific emphasis on empowering women to spearhead positive transformations in the healthcare landscape through a focus on airway health.

Vivos was granted 510(k) clearance from the U.S. Food and Drug Administration (FDA) on November 28, 2023 for treating severe OSA in adults using the Vivos’ removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances. Vivos’ CARE appliances include the flagship DNA oral appliance, the mRNA oral appliance, and the mmRNA oral appliance. This represents the first time the FDA has ever granted an oral appliance a clearance to treat moderate and severe OSA in adults, 18 years of age and older along with positive airway pressure (PAP) and/or myofunctional therapy, as needed

Dr. Manisha Witmans, a board-certified sleep specialist licensed in both the United States and Canada, expressed, “I’m grateful to be speaking at the Empowering Women to Champion Airway event which is a tremendous opportunity to enhance collaboration between medical and dental professionals regarding treatment of patients with OSA. The recent FDA 510(k) clearance for Vivos’ CARE devices to address severe OSA is encouraging for both patients and clinicians as this gives medical professionals a new and potentially more desirable option to offer to their patients. Severe OSA is a prevalent and often underdiagnosed condition and immediate treatment is critical as it can worsen the outcomes of various diseases and contribute to premature death. Unfortunately, many patients have remained untreated due to the drawbacks of CPAP or invasive surgeries. Collaborative efforts between medical doctors and dentists are essential to provide optimal treatment solutions for all patients.”

Susie McCullough, executive vice president of Vivos stated, “We are honored to host such an all-star lineup of world-renowned speakers with expertise in a variety of healthcare specialties—including medical sleep specialists, cardiologists, primary care physicians, pediatric specialists, orthodontists, and general dentists—all of whom work in one way or another with sleep and breathing disorders. Fostering this type of interdisciplinary collaboration is necessary to increase the awareness that there is a new alternative to CPAP or surgery for treating severe OSA.”

McCullough continued, “Not only are today’s women assuming an ever-increasing level of prominence and leadership roles within healthcare, but women continue to exert the greatest influence over family healthcare decisions. As spouses, mothers and caregivers, we are often on the frontlines of dealing with the effects of OSA, snoring, insomnia and other breathing and sleep problems. We need to know what we’re dealing with and the latest remedies that are available, with a particular emphasis on ensuring the well-being of young patients through early intervention Vivos is proud to host this first-of-its-kind event, offering a special opportunity to glean insights into how women can drive innovation and progress in this critical facet of healthcare.”

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults.

The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to severe OSA. It has proven effective in approximately 40,000 patients treated worldwide by more than 1,850 trained dentists.

The Vivos Method includes treatment regimens that employ the proprietary Vivos Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-severe OSA, such as lowering Apnea Hypopnea Index scores.


Source: www.vivos.com

Related articles

Presto Smile, a leading innovator in dental technology, is thrilled to announce the upcoming launch of its proprietary AI-powered platform in January 2024. This groundbreaking development will assist...


Marnie Oakley, DMD, Pitt’s new School of Dental Medicine dean, has never really lost that awestruck feeling she experienced the first time she walked onto the University of Pittsburgh’s campus as...


Today is International Women’s Day. Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, actively advocates for a greater focus on women’s...


U.S. Oral Surgery Management (USOSM) chief operations officer Alisa Ulrey and USOSM chief human resources officer Annette Igl will be panel speakers in the upcoming Empower and Grow conference,...


Dental Innovation Alliance (DIA) and Women in DSO (WinDSO) proudly announce a strategic partnership aimed at advancing women as entrepreneurs and investors in the dental industry.


Read more

The Columbia University College of Dental Medicine (CDM) and the Fu Foundation School of Engineering and Applied Science have received approval from the New York State Department of Education to...


Dr. Richard Eidelson, DDS, MAGD, a nationally recognized leader in cosmetic dentistry, is thrilled to announce the opening of his second dental practice, Premier Dentist Philadelphia, located in the...


DDS Lab (DDS), one of the largest full-service dental laboratories in the world, today announced the commencement of operations out of its new state-of-the-art, full-service dental laboratory based...


The global electric toothbrush market size is estimated to grow by USD 2780 million from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of over 8.24% during the...


 
 
 
 

 
 
 
 

Most popular

 
 

Events